Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
Lymphoma
About this trial
This is an interventional treatment trial for Lymphoma focused on measuring stage I adult diffuse large cell lymphoma, stage III adult diffuse large cell lymphoma, stage IV adult diffuse large cell lymphoma, contiguous stage II adult diffuse large cell lymphoma, noncontiguous stage II adult diffuse large cell lymphoma, angioimmunoblastic T-cell lymphoma
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of diffuse large B-cell or peripheral T-cell non-Hodgkin's lymphoma (NHL) No Burkitt's-like lymphoma Small cells in bone marrow allowed Previously untreated NHL At least 1 measurable lesion At least 1.1 cm Poor physiological status with at least 1 of the following: WHO performance status of 3-4 LVEF less than 50% Creatinine clearance less than 50 mL/min Neutrophil count no greater than 1,500/mm^3 Platelet count no greater than 100,000/mm^3 Concurrent severe disease that would preclude cyclophosphamide, vincristine, prednisolone, and doxorubicin No cerebral or meningeal involvement PATIENT CHARACTERISTICS: Age: 70 and over Performance status: See Disease Characteristics Life expectancy: Not specified Hematopoietic: See Disease Characteristics Hepatic: Not specified Renal: See Disease Characteristics Other: HIV negative No other malignancy within the past 5 years except adequately treated basal cell skin cancer, curatively treated carcinoma in situ of the cervix, or curatively treated solid tumor No active infection No psychological, familial, sociological, or geographical condition that would preclude study participation PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease Characteristics Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: Not specified Other: No other concurrent investigational drugs No other concurrent antineoplastic agents
Sites / Locations
- Ziekenhuis Network Antwerpen Middelheim
- Centre Hospitalier Universitaire Brugmann
- U.Z. Gasthuisberg
- National Cancer Institute of Egypt
- Centre D'Oncologie Du Pays-Basque
- Hopital Saint Andre
- Institut Bergonie
- Centre Hospitalier de Dax
- Hopital Robert Boulin
- Polyclinique de Francheville
- Onze Lieve Vrouwe Gasthuis
- Academisch Ziekenhuis Groningen
- University Medical Center Nijmegen
- Hospitais da Universidade de Coimbra (HUC)
- Hopitaux Universitaires de Geneve
- New Cross Hospital
- Dumfries Royal Infirmary